Variantyx
Framingham, US · Founded 2014 · Delaware corporation · 219 employees on LinkedIn · 9 known investors
Variantyx is a molecular diagnostics company offering genetic testing for rare genetic disorders, reproductive genetics, and precision oncology. It serves healthcare providers using proprietary laboratory technology and AI/ML analytical tools for genomic testing and personalized medicine.
Founders & leadership
Variantyx was founded in 2014 by Haim Neerman and Tomer Jackman.
HN
TJ
Tomer JackmaninCo-founder & VP Customer Support and Lab Services
JW
Jeffrey WeisberginChief Financial Officer
YR
Yaron RachmanyinOperations, R&D, IT (executive)
CS
Christine StanleyinChief Genomics and Compliance Officer
ER
Eyal ReinsteininChief Medical Officer
TD
Tom DeLucainChief Human Resources Officer
GF
Greg FaustNamed on SEC filing
Board
ZA
Zafrira AvnurBecame a director following financing closing.Advisory Board at 20/20 HealthCare Partners LLC
HB
NS
Noam ShomronWas a director at financing closing.
Investors · 9
20/20 HealthCare Partners LLC✓ verifiedAuburndale
Bosch Ventures✓ verifiedStuttgart · $27M
New Era Capital Partners✓ verifiedTel Aviv
OrbiMed✓ verifiedNew York · $1M – $75M
Peregrine Ventures✓ verifiedOr Yehuda · $500K – $3M
Pitango✓ verifiedTel Aviv · $4M – $100M
Quark Venture Inc.✓ verifiedVancouver
Soleus Capital✓ verifiedGreenwich
Robert Bosch Venture CapitalStuttgart · $1.6M – $27M
Funding
SEC filings, press & company announcements$51.6M disclosed across 2 rounds · 2021–2024
- $36MraisedApr 2024 · 3 sources
Bosch Ventures, New Era Capital Partners, Peregrine Ventures, Pitango HealthTech
Source ↗
▶$15.6MraisedMar 2021 · 8 investors · Other TechnologyRule 506(b)
▶$15.6MraisedMar 2021 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Zafrira AvnurDirector
- Hillel BachrachDirector
- Noam ShomronDirector
- Greg FaustDirector
- Haim NeermanExecutive Officer, Director
- Offering amount
- $20.1M
- Amount sold
- $15.6M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlapLabcorp149 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Quest Diagnostics130 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Myriad116 shared keywordsMyriad provides germline and tumor genomic testing across hereditary cancer, prenatal and reproductive health, prostate cancer, and pharmacogenomics for mental health medications. It supplies patients and healthcare providers with genetic screening results and AI-derived insights to inform diagnosis, risk assessment, and treatment decisions.
Genedx112 shared keywordsGeneDx provides genetic testing for rare and inherited conditions, including exome, genome, trio, and prenatal sequencing, paired with clinical interpretation and a large rare disease dataset. It serves clinicians, patients, and biopharma partners to support earlier diagnoses and precision medicine.
Invitae110 shared keywordsInvitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life. Now part of Labcorp, the company leverages a nationwide network of patient service centers and coverage by most health plans to make genetic testing more accessible.
Sequencing75 shared keywordsSequencing.com provides whole genome sequencing with a DNA collection kit and DNA reports offering health, wellness, and pharmacogenomic insights for consumers. It offers an optional subscription that reanalyzes a customer's genome monthly against the latest research and gives full access to raw and analyzed genetic data.
IDbyDNA73 shared keywordsScalable, high throughput DNA sequencing platforms.
Companies competing with Variantyx for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Variantyx do?
- Variantyx is a molecular diagnostics company offering genetic testing for rare genetic disorders, reproductive genetics, and precision oncology. It serves healthcare providers using proprietary laboratory technology and AI/ML analytical tools for genomic testing and personalized medicine.
- Who founded Variantyx?
- Variantyx was founded by Haim Neerman, Tomer Jackman in 2014.
- Who are Variantyx's investors?
- Variantyx's investors include 20/20 HealthCare Partners LLC, Bosch Ventures, New Era Capital Partners, OrbiMed, Peregrine Ventures, Pitango, Quark Venture Inc., Soleus Capital and 1 more.
- How much funding has Variantyx raised?
- Variantyx has disclosed $51.6M raised across 2 rounds.
- Where is Variantyx headquartered?
- Variantyx is headquartered in Framingham, US.